Catalyst Wire Dossier Catalyst Wire Dossier

Ranpirnase

ranpirnase · Tamir Biotechnology, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ranpirnase, covering 2018-06-06 to 2018-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) [Phase 1, Phase 2]

See pricing